CURRENT ISSUE [Volume 4, Isuue 1, 2019]
-
Autism Spectrum Disorder: Medications overview2019, Volume 4, Issue 1, 77-80 [Download Full PDF]
- FDA-approves the first therapy in 2018 for the seizures associated with Dravet syndrome
2019, Volume 4, Issue 1, 81-84 [Download Full PDF]
- Cannabidiol: FDA approved new drug for the Lennox-Gastaut syndrome and Dravet syndrome: Pharmacotherapeutics review
2019, Volume 4, Issue 1, 85-89 [Download Full PDF]
- Caplacizumab: First FDA-approved therapy in 2019 for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura
2019, Volume 4, Issue 1. 90-93 [Download Full PDF]
- Stiripentol: New approved drug for the Dravet syndrome: Pharmacotherapeutics review
2019, Volume 4, Issue 1, 94-98 [Download Full PDF]